Effect of real-time continuous glucose monitoring system in overweight or obese adults with prediabetes
- Conditions
- Endocrine, nutritional and metabolic disease
- Registration Number
- KCT0004304
- Lead Sponsor
- Pusan National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
1. = BMI 23 kg/m2
2. impaired fasting glucose (fasting glucose 100 to 125?mg/dL) or impaired glucose tolerance (2-h plasma glucose during oral glucose tolerance test (OGTT) 140 - 199 mg/dl) or HbA1c 5.7% to 6.4%
1. type 1 diabetes or type 2 diabetes or undergoing treatment for diabetes
2. clinical history including malignancy
3. fast history of cardiovascular disease (e.g. myocardial infarction, stroke), surgery, and trauma which may affect blood glucose within last 6 months
4. taking medication (e.g. glucocorticoid, antipsychotics, anticholinergic drug etc.) which affect blood glucose
5. acute infection within last 1 month
6. pregnancy
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1C change;weight(Kg) change
- Secondary Outcome Measures
Name Time Method lipid profile (total cholesterol, triglyceride, LDL-cholesterol and HDL-cholesterol) change